Sulfate plays an essential role in human growth and development, and its circulating levels are maintained by the renal Na + -SO 4 2-cotransporter, NaS1. We previously generated a NaS1 knock-out (Nas1 -/-) mouse, an animal model for hyposulfatemia, which exhibits reduced growth and liver abnormalities, including hepatomegaly. In this study, we investigated the hepatic gene expression profile of Nas1 -/-mice using oligonucleotide microarrays. The mRNA expression level of 92 genes with known functional roles in metabolism, cell signaling, cell defense, immune response, cell structure, transcription or protein synthesis, were increased (n=51) or decreased (n=41) in Nas1 -/-mice when compared with Nas1 +/+ mice. The most upregulated transcript levels in Nas1 -/-mice were found for the sulfotransferase genes, Sult3a1
Introduction
Inorganic sulfate (SO 4 2- ) is the fourth most abundant anion in mammalian plasma, and is essential for numerous metabolic and cellular processes (38). The biotransformation of molecules by sulfonation is an important metabolic route in the metabolism of xenobiotics and many endogenous compounds, including hormones, neurotransmitters and bile acids (20) .
In addition, sulfonation of structural components, such as proteins, lipids and glycosaminoglycans, is essential for the maintenance of normal structure and function of tissues (40).
The liver is a major site for the sulfonation of numerous compounds, due to its high sulfotransferase activities and abundant levels of the sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS) (8) . Hepatic sulfonation is an important process for decreasing the toxicity of secondary bile acids, such as lithocholate, especially during intrahepatic cholestatic conditions, including progressive familial intrahepatic cholestasis type I (PFIC1) and intrahepatic cholestasis of pregnancy (ICP) (42, 44). Defective lithocholate sulfonation activity in rhesus monkeys was shown to lead to an accumulation of lithocholic acid in the liver and hepatotoxicity (24). Hepatic sulfonation also has a significant role in the metabolism of catecholamine neurotransmitters, steroids and iodothyronines (52). The liver also utilizes sulfate to detoxify many phenolic compounds found in food (39). In addition, sulfoconjugation is an important step in the metabolism of certain drugs, including the common analgesic, acetaminophen (40). Studies in rats have shown that sulfur-deficient diets can lead to reduced blood and hepatic sulfate levels, and increased acetaminophen-induced hepatotoxicity (45). Taken together, these findings underscore the importance of maintaining sufficiently high levels of sulfate for sulfonation reactions to function efficiently in the liver.
Despite the importance of sulfate in the body, plasma SO 4 2-levels are rarely measured clinically and little is known about the physiological consequences of hyposulfatemia. In humans, the sodium sulfate cotransporter, NaS1, is expressed primarily in the kidney (34) where it is proposed to maintain plasma SO 4 2-levels (41). We have cloned the human and mouse NaS1 genes, designated NAS1 (34) and Nas1 (2), respectively. More recently, we generated a NaS1 null (Nas1 -/-) mouse which exhibits hyposulfatemia, reduced growth, decreased serum IGF-1 levels, altered serum bile acid concentrations, increased hepatic sulfotransferase activity, and hepatomegaly (16) . One approach towards understanding these abnormal features in the Nas1 -/-mouse, is through the use of transcriptional profiles.
Transcriptional profiling has become a valuable tool for investigating gene expression in mammalian physiology. In particular, studies of the murine hepatic transcriptome have led to the discovery of genes that are regulated by diet (19) , caloric restriction (7), hormones (21) and circadian rhythm (1) . The important role of the liver in sulfonation, makes the hepatic transcriptome an appropriate starting place to investigate the molecular consequences of hyposulfatemia. Of particular relevance to our studies of the Nas1 -/-mouse, is that blood sulfate levels are reduced under certain physiological conditions, including ageing (12) , and also in certain neurological disorders, such as Alzheimer's, Parkinson's, Motor Neurone disease and autism (27, 55). However, the etiology of hyposulfatemia in these neurological
disorders is yet unknown. In addition, low dietary sulfate intake and medications, such as acetaminophen, have also been linked to reduced blood sulfate levels (29, 45). The aim of this study was to determine if the transcriptional profile was altered in the liver of hyposulfatemic Nas1 -/-mice. Our findings demonstrate changes to hepatic gene expression in Nas1 -/-mice, and together with biochemical and histological analyses, suggest that hyposulfatemia may lead to a shift in energy metabolism in the liver from carbohydrate to fatty acid utilization.
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Materials and Methods
Mice. We previously generated Nas1 knock-out (Nas1 -/-) mice in which the NaS1 gene was disrupted by targeted mutagenesis (16 Gene expression profiling. Since circadian rhythm is known to alter hepatic gene expression
(1), we isolated total RNAs from the livers of 4 week old male Nas1 +/+ and Nas1 -/-mice (n = 14 for each genotype) at 0900h, using previously described methods (16) . Total RNAs were amplified, labeled and hybridized overnight at 42 o C using previously described methods (10) and 22K mouse Compugen long oligonucleotide arrays from the SRC Microarray Facility, University of Queensland (ARC Centre for Functional and Applied Genomics).
Liver RNAs from Nas1 +/+ and Nas1 -/-mice were directly compared in quadruplicate with dyeswapping incorporated into 2 of the hybridisations to account for bias. Arrays were scanned on an Agilent scanner 600B (Agilent Technologies Inc.) and foregound/backgroud signal intensities quantified using Imagene5.0 (BioDiscovery Inc). All data was normalised using a combination of the Printtiplowess and scaling between arrays algorithms from Bioconductor (LIMMA) and SMA (50 Red O, and then counterstained with hematoxylin. Periodic Acid Schiff staining was used for the detection of glycogen. All sections were examined by light microscopy at 40x magnification.
Measurement of Liver Lipid and Glycogen Levels.
Total liver lipids were extracted by using described methods (23) . Lipid content was calculated from the weight of the dried lipids (mg lipid / mg liver). Liver glycogen content was quantitated by using a colorimetric assay 
Results
Hepatic transcriptional profile of Nas1 -/-mice. We recently reported physiological abnormalities in Nas1 -/-mice, including growth retardation, reduced serum IGF-1 levels, hepatomegaly, increased sulfotransferase activity and altered serum bile acid levels (16).
These findings led us to study the hepatic gene expression profile of Nas1 -/-and Nas1 +/+ mice using cDNA microarrays, which revealed transcriptional differences in the Nas1 -/-mice. Since numerous studies have shown that small changes (< 2-fold) in gene expression can be important in critical biological pathways (51), we have listed all genes that showed significant changes, as assessed statistically at B > 0.0 (Tables 2 and 3 ). Similar total numbers of genes were up-(n = 66) and down-regulated (n = 64) in Nas1 -/-livers, when compared to Nas1
livers. Of the 130 genes that were differentially transcribed, 38 were not annotated for molecular function using the Clonefinder and DAVID databases and are therefore not discussed hereafter. 
Nas1
-/-mice ( Fig. 2A ) when compared to Nas1 +/+ mice (Fig. 2B ). In addition, decreased glycogen content, as indicated by PAS staining, was observed in the Nas1 -/-livers ( Fig. 2C) when compared to livers of Nas1 +/+ mice (Fig. 2D) . Quantification of liver lipid content ( Fig.   2E ) revealed an ≈16% increase in Nas1 -/-mice (7.7 ± 0.5 %, n = 7; P = 0.0001) when compared with Nas1 +/+ mice (6.6 ± 0.2 %, n = 7), further confirming the fatty liver phenotype.
The hepatic glycogen content in Nas1 -/-mice (0.80 ± 0.17 µg/mg protein, n = 7, P = 0.025) determined by colorimetric analysis was ≈50% of the glycogen level in Nas1 +/+ mice (1.50 ± 0.22 µg/mg protein, n = 7) (Fig. 2F ). These changes in hepatic lipid and glycogen content, found in 4 week old Nas1 -/-mice, prompted us to compare the food intake of Nas1 +/+ and Nas1 -/-mice from 3 to 4 weeks of age. Food intake in Nas1 -/-mice (11.8 ± 1.6 g, n = 7) was not significantly different (P = 0.63) to that of Nas1 +/+ mice (13.0 ± 1.5 g, n = 5).
Blood lipid and glucose data. Since hepatic lipid and glycogen levels of Nas1 -/-mice were significantly different from their Nas1 +/+ littermates, we measured blood lipid and glucose parameters in the Nas1 -/-and Nas1 +/+ mice (Table 4) . No significant differences were found in whole blood HDL, VLD, triglycerides and glucose, but significant increases in blood concentrations of LDL (100%, P = 0.006), total cholesterol (TC) (≈20%, P = 0.008) and the TC/HDL ratio (>30%, P = 0.037) were observed in Nas1 -/-mice when compared with Nas1
littermates.
Sulfate transporter mRNA levels in Nas1 -/-mice. We examined the mRNA levels of three sulfate transporters: diastrophic dysplasia sulfate transporter (dtdst), down-regulated in adenoma (dra), and sulfate anion transporter-1 (sat-1) (26, 35, 49) . Using microarray analyses, no changes (B<0) in dtdst and dra mRNA expression were observed in Nas1 -/-mice. Since the sat-1 cDNA was not present on the gene array used in this study, we used Northern hybridization ( Fig. 3A) and RT-PCR (data not shown) to determine sat-1 mRNA expression in the livers of Nas1 -/-mice. sat-1 mRNA levels were increased in Nas1 -/-(≈280%) and Nas1 +/-(≈120%) mice, when compared with Nas1 +/+ littermates (Fig. 3B) .
Genes involved in sulfate and amino acid metabolism. 
Discussion
In this study, we demonstrated an altered hepatic gene expression profile in hyposulfataemic Nas1 -/-mice. These transcriptional changes were associated with increased levels of hepatic lipid, serum cholesterol and LDL, reduced hepatic glycogen levels, and no changes in blood HDL, VLD, triglycerides, glucose, and food intake. Since NaS1 mRNA is not expressed in the liver (2), we propose that the altered transcriptional profile of Nas1 -/-mice is most likely due to reduced sulfate availability in the liver, as a consequence of hyposulfatemia found in Nas1 -/-mice (16). ) mice exhibit fatty liver and reduced hepatic glycogen levels (14) , which is consistent with the decrease in hepatic Mt1 mRNA levels observed in Nas1 -/-mice ( Table 3 ).
Nas1
The increased hepatic lipid level and low glycogen content in Nas1 -/-mice could also be explained by reduced nutrition. Both caloric restriction (CR) and chronic malnutrition causes glycogenolysis and mobilization of fatty acids to the liver where they are oxidized by the mitochondrial β-oxidation, peroxisomal β-oxidation and cytochrome-catalyzed microsomal ω-oxidation pathways, leading to the export of ketone bodies out of the liver to serve as fuels for other tissues (6, 28) . This is consistent with Nas1 -/-mice having increased levels of Cyp2b13 mRNA, a cytochrome p450 which oxidizes fatty acids and is transcriptionally induced by CR (18) and ketone bodies (56). While the present study demonstrated that food intake of Nas1 -/-mice was similar to that of Nas1 +/+ mice, future studies will be aimed at determining whether Nas1 -/-mice have altered nutritional absorption and amino acid breakdown, as previously shown for malnutrition [reviewed in (11) ]. However, our transcriptional profiling showed no changes in genes involved in amino acid metabolism, including the sulfhydryl-containing amino acids methionine and cysteine, suggesting amino acid metabolism may not be altered in Nas1 -/-mice. Nonetheless, the present study suggests that SO 4 2-may be an important factor in the modulation of hepatic lipid and glycogen levels.
-/-mice exhibit increased serum LDL and total cholesterol (TC) levels. The findings of increased blood TC and LDL levels in Nas1 -/-mice could be associated with an upregulation of genes involved in cholesterol biosynthesis (Mvd) and metabolism (Insig1). (17)], we need to consider the possibility that the increased serum bile acid levels, found in the Nas1 -/-mice (16), may be contributing to the altered hepatic transcriptional profile of Nas1 -/-mice. However, we found no changes in the mRNA level of genes involved in bile acid-sensing, such as the hepatocyte nuclear factor 4 (Hnf4a) and farnesoid X receptor (Nr1h4). In addition, the lack of similarities between the Nas1 -/-hepatic transcriptional profile and that obtained from the livers of mice fed a cholate-and cholesterol-enriched diet (54) or ursodeoxycholic acid-treated rat hepatocytes (9) , suggests that the altered mRNA profile of Nas1 -/-mice, may be due to entities other than increased serum bile acid levels (16) and mild hypercholesterolemia (Table 4) found in Nas1 -/-mice.
-/-mice exhibit altered sulfotransferase mRNA levels. Three members of the sulfotransferase gene family with functional links to steroid metabolism, were up-(Sult3a1 and Sult2a2) or down-regulated (Sult1e1) in livers of Nas1 -/-mice. Both Sult3a1 and Sult2a2
can sulfonate a variety of steroids and sterols, including dehydroepiandrosterone (DHEA) (3).
The serum concentration of DHEA-sulfate (DHEA-S) is normally 300-500 times higher than that of DHEA (33), suggesting that DHEA-S forms a circulating reservoir. However, only the un-conjugated steroid hormone DHEA has growth-promoting activity, and changes in the activity of DHEA sulfotransferases have been implicated in pathophysiological disorders of growth (32). Nas1 -/-mice exhibit reduced growth (16) , and future studies of steroid hormone levels in these mice will determine the consequences of increased Sult3a1 and Sult2a2 mRNA levels on DHEA metabolism. In addition, the strong induction of Sult3a1, which also catalyzes the sulfate conjugation of p-nitrophenol, is consistent with our previous findings of elevated hepatic sulfotransferase activity (16) . However, unlike the up-regulation of Sult3a1
and Sult2a2, we observed reduced mRNA levels of Sult1e1, suggesting that members of the sulfotransferase family may be differentially regulated at the transcriptional level in Nas1 -/-mice. Sult1e1 catalyzes the sulfonation of β-estradiol and estrone, and has an important role in mammalian reproductive physiology (53). Disruption of the mouse Sult1e1 gene results in reproductive abnormalities of female mice as soon as they reach sexual maturity, whereas male sult1e1 null mice develop testicular abnormalities and a decreased fertility later in adulthood (46). Interestingly, female Nas1 -/-mice have reduced fertility at sexual maturity, which was not seen in male Nas1 -/-mice at 2-6 months of age (16) . However, the fertility of male Nas1 -/-mice aged >6 months, is yet to be determined. Also down-regulated was AKr1c18, a hydroxysteroid dehydrogenase which is essential in estrogen biosynthesis. The solute carrier organic anion transporter, Slco1b2, which mediates the transport of steroids from the liver, including DHEA-S and estrone-sulfate, was also suppressed in Nas1 -/-mice. In addition, the Cyp3a25 microsomal cytochrome, known to be involved in steroid oxidation, was transcriptionally down-regulated in Nas1 -/-mice. Taken together, these data show an altered transcriptional profile of genes linked to steroid metabolism, which may be relevant when considering the etiology of reduced growth and fertility in Nas1 -/-mice.
Transcriptional changes associated with immune response and cell defence. The liver is
an essential part of the immune system, producing defensin and acute phase proteins (25) .
Several defensin (Defcr2, Defcr9, Defcr6 and Defb6), heat shock (Hspa5, Hspb1 and Hspa8), immune response (Gbp2 and Xbp1) and acute-phase response (Itih3) genes were up-regulated in Nas1 -/-mice (Table 2) . Similar transcriptional responses were reported during acute systemic inflammation (13) . However, Nas1 -/-mice showed no evidence of liver inflammation in H&E-stained sections (16) , suggesting an injury in extrahepatic tissues. During acute stress, hepatocyte proliferation and steatosis is stimulated (15) , which is consistent with our findings of hepatomegaly (16) and fatty liver (Fig. 2) in Nas1 -/-mice. It is also consistent with the up-regulation of several genes linked to protein synthesis (Eef1g, Yars, Rpl8 and Gfm) and cell growth (Igfbp2, Igtp and Tgtp) ( Table 2) .
Increased hepatic sat-1 mRNA levels in Nas1 -/-mice. Previously, we cloned the mouse sulfate anion transporter-1 gene (sat-1), which is strongly expressed in the liver, where it is proposed to play a role in bile acid metabolism (35). In the present study, we showed increased sat-1 mRNA levels in the livers of Nas1 -/-and Nas1 +/-mice, which was most likely a compensatory response to reduced serum sulfate levels in Nas1 -/-(0.22 mM) and Nas1 +/-(0.56 mM) mice (16) . We have characterized the mouse sat-1 gene promoter to have numerous and diverse transcription factor binding sites (36), including a functional T 3 response element (35). To date, no studies have examined the effect of hyposulfatemia on thyroid hormone levels, but the lack of similarities between the Nas1 -/-hepatic transcriptional profile and that obtained from T 3 -treated and hypothyroid mice (22) , may argue against a change in thyroid hormone levels in Nas1 -/-mice. Our data here suggests that sat-1 mRNA expression (Fig. 3 ) is sensitive to changes in blood sulfate levels, as observed in Nas1 +/-mice with a ≈50% reduction in serum sulfate levels (16) . Alternatively, the mRNA levels of two other sulfate transporters, dtdst (slc26a2) and dra (slc26a3), were not changed, indicating that they may not be sensitive to altered blood sulfate levels. In addition, no change was found for genes involved in sulfate metabolism, sulfonation of proteoglycans, or the metabolism of sulfur containing amino acids, including cysteine, methionine and glutathione. Taken together, the transcriptional changes in sat-1 and sulfotransferases (Sult3a1 and Sult2a2), are most likely due to low hepatic sulfate levels as a consequence of hyposulfatemia.
Summary. In conclusion, this study has revealed that NaS1 sulfate transporter deficiency leads to an altered hepatic transcriptional profile, increased hepatic lipid and blood cholesterol levels, and decreased hepatic glycogen content. These findings suggest that sulfate may play important, and previously undescribed, roles in the modulation of energy metabolism in the liver and in blood cholesterol homeostasis. The significance of hyposulfatemia on hepatic metabolism and blood cholesterol levels in humans, awaits further investigation.
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Nas1
-/-mice when compared with Nas1 +/+ mice. RNA was isolated from the livers of 14
-/-mice and 14 Nas1 +/+ littermates, and 4 replicates of a mixed RNA pool were evaluated. mice. Each bar represents the mean ± SD of measurements from 7 Nas1 -/-and 7 Nas1 +/+ mice. **, P = 0.0001 and *, P = 0.025 when compared with Nas1 +/+ mice. Table 2 . Genes up-regulated in Nas1 -/-liver. Results are means ± SD (n, number of mice). *, P = 0.037, **, P = 0.008 and ***, P = 0.006 when compared with Nas1 +/+ mice.
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